The heterodimeric ␣␤ T cell receptor (TCR) for antigen is the key determinant of T cell specificity. The structure of the TCR is very similar to that of antibodies, but the engineering of TCRs by directed evolution with combinatorial display libraries has not been accomplished to date. Here, we report that yeast surface display of a TCR was achieved only after the mutation of specific variable region residues. These residues are located in two regions of the TCR, at the interface of the ␣-and ␤-chains and in the ␤-chain framework region that is thought to be in proximity to the CD3 signal-transduction complex. The mutations are encoded naturally in many antibody variable regions, indicating specific functional differences that have not been appreciated between TCRs and antibodies. The identification of these residues provides an explanation for the inherent difficulties in the display of wild-type TCRs compared with antibodies. Yeastdisplayed mutant TCRs bind specifically to the peptide͞MHC antigen, enabling engineering of soluble T cell receptors as specific T cell antagonists. This strategy of random mutagenesis followed by selection for surface expression may be of general use in the directed evolution of other eukaryotic proteins that are refractory to display.
T cell receptors (TCRs) and antibodies have evolved to recognize different classes of ligands. Antibodies function as membrane-bound and soluble proteins that bind to soluble antigens, whereas TCRs function only as membrane-bound molecules that bind to cell-associated peptide͞MHC antigens. All of the energy of the antibody:antigen interaction focuses on the foreign antigen, whereas a substantial fraction of the energy of the TCR:peptide͞MHC interaction seems to be directed at the self-MHC molecule (1) . In addition, antibodies can have ligand-binding affinities that are orders of magnitude higher than those of TCRs, largely because of the processes of somatic mutation and affinity maturation. In their normal cellular context, TCRs do not undergo somatic mutation and the processes of thymic selection seem to operate by maintaining a narrow window of affinities (2) . The association of TCRs at the cell surface with the accessory molecules CD4 or CD8 also may influence the functional affinity of TCRs (3) . Despite these differences, the three-dimensional structures of the two proteins are remarkably similar, with the hypervariable regions forming loops on a single face of the molecule that contacts the antigen (4) (5) (6) (7) .
Based on their structural similarities, it is somewhat surprising that there have been significant differences in the success of producing soluble and surface-displayed forms of the extracellular domains of TCRs and antibodies in heterologous expression systems. Many antibodies have now been expressed at high yield and solubility as either intact or Fab-fragment forms or as single-chain (sc) fragment-variable (Fv) proteins. In addition, there are numerous antigen-binding Fv fragments that have been isolated de novo and͞or improved through the use of phage-display technology and, more recently, with yeast-display technology (8, 9) . These expression systems for antibody fragments have been key in structural studies and in the design of diagnostic and therapeutic antibodies.
In contrast, the three-dimensional structures of a few TCR molecules were determined only after considerable effort on the expression of soluble, properly folded TCRs (10) . One of the difficulties in exploring the basis of differences between Fab and TCR is that the extensive sequence diversity in antibody and TCR variable (V) regions complicates efforts to discern what features of the V regions might be important for functions other than antigen binding (e.g., V region pairing and association kinetics, stability, and folding). There have been relatively few studies that have compared the V regions of TCRs and antibodies in terms of these properties (11) .
Nevertheless, the TCR from the mouse T cell clone 2C has now been expressed as an sc V ␣ V ␤ (scTCR) from Escherichia coli (12) , as a lipid-linked V ␣ C ␣ V ␤ C ␤ dimer from myeloma cells (13) , and as a secreted V ␣ C ␣ V ␤ C ␤ dimer from insect cells (6) . The 2C scTCR had relatively low solubility compared with most scFv, although its solubility is increased Ϸ10-fold by fusion at the amino terminus to thioredoxin (14) . The difficulty in generating soluble, properly folded V ␣ V ␤ domains has extended to other TCRs (15) (16) (17) . The molecular explanation for the apparent differences between TCR and Fv in either solubility or surface-display capability has not been explored adequately. In this report, we show that the 2C scTCR can be expressed in a yeast surface-display system (8, 9) after the selection, from a random library, of specific single-site mutations at the V ␣ ͞V ␤ interface or in a region of the V ␤ framework suspected to interact with the CD3 signal-transduction subunit. These mutations, several of which are found naturally in antibody V regions, indicate the significance of these positions in the TCR and provide a basis for further engineering of TCR-binding properties. In addition, the strategy described here that allowed display of the TCR may be of general use in the study and directed evolution of other proteins that cannot be displayed on the cell surface in their wild-type form.
MATERIALS AND METHODS

Random Mutagenesis and Expression of 2C TCR.
A library of mutant plasmids containing the 2C TCR gene (V ␤ 8.2-linker-V ␣ 3.1) was generated by using the E. coli mutator strain
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Abbreviations: TCR, T cell receptor; Fv, fragment variable; sc, singlechain; V, variable; SA-PE, streptavidin-phycoerythrin; FR1, first framework region. § To whom reprint requests should be addressed. e-mail: d-kranz@ uiuc.edu or wittrup@uiuc.edu. XL1-Red (Stratagene). Plasmids were transfected into yeast, and surface-displayed TCRs were selected by using fluorescence cell sorting as described (8, 9) . Selection of Mutant TCRs by Using Flow Cytometry. A library of yeast cells that were transfected with the mutagenized TCR plasmids was incubated with 25 l of antibody 1B2 conjugated to biotin (20 g͞ml), washed with buffer (PBS͞0.1% BSA), and incubated with streptavidin-phycoerythrin (SA-PE, 1:200, PharMingen). After washing, samples were sorted on a Coulter 753 bench sorter with an event rate of Ϸ4,000 cells per s. A total of 6 ϫ 10 7 cells were examined during the first sorting round, and Ϸ5% of the population was collected. Collected cells were regrown at 30°C in selective glucose medium for Ϸ18-20 h, and TCR surface expression was induced at 20°C in selective galactose medium. After three rounds of sorting, collected cells were re-sorted and plated on selective medium to isolate individual clones. Flow cytometry with 1B2 conjugated to biotin and SA-PE was used to examine 20 clones further, and plasmids from 17 colonies were rescued for sequencing.
Estimation of TCR per Cell. Yeast expressing mutant TCR (10 7 cells in 10 l) were incubated with various concentrations of 125 I-labeled 1B2 Fab fragments (total volume of 30 l) on ice for 1 h in round-bottom 96-well plates. The mixture was layered over 300 l of 80% (vol/vol) dibutyl phthalate͞20% (vol/vol) olive oil in plastic tubes, and the tubes were microfuged for Ϸ2-3 s. Tubes were frozen on dry ice. Cell pellets containing bound 125 I-labeled 1B2 Fabs were counted, and the cpm of 125 I-labeled 1B2 Fab added was plotted as a function of cpm bound. To estimate the total number of receptors per yeast cell, results from the highest concentration of 125 I-labeled 1B2 Fabs tested (Ϸ70 ng͞ml) were compared with results obtained by using 2C T cells, for which there are 100,000 receptors per cell (18) .
Peptide͞MHC Functional Binding Assay. Soluble peptide͞ MHC protein (peptide͞L d ) was prepared from Drosophila melanogaster cells as described by Garcia et al. (3) . MHC molecules were purified by Ni-agarose (Ni 2ϩ ͞nitrilotriacetic acid͞agarose; Qiagen, Chatsworth, CA) step-gradient affinity chromatography and ion-exchange chromatography [Mono Q in 50 mM Tris (pH 8.0), 0-500 mM NaCl gradient; Amersham Pharmacia]. Before the competition assays, nonspecific (MCMV) or specific (QL9) peptides were incubated with the soluble MHC protein͞L d preparations for Ϸ1 h at 4°C.
To examine binding of soluble peptide͞MHC to yeast cells displaying mutant TCR, the amount of 125 I-labeled 1B2 Fabs that yielded Ϸ400-600 cpm bound in the absence of inhibitor was used in a competitive ligand binding assay (i.e., more Fab was required for yeast that expressed lower levels of TCR to achieve this amount of bound 1B2). Yeast (10 7 
.
RESULTS
Expression and Detection of the 2C TCR on the Yeast Cell Surface. The yeast-display system has been used to express different scFv regions as fusion proteins with a yeast-mating agglutination receptor subunit, Aga-2p (8, 9) . Similarly, the gene encoding the scTCR (V ␤ -linker-V ␣ ) region from the T cell 2C was cloned into this system as a fusion with Aga-2p and a short epitope tag (HA ), but its affinity is over 100 times higher than the peptide͞MHC interaction (1); as such, 1B2 was used as a high-affinity probe for the detection of properly folded 2C TCRs (20) .
Expression of properly folded wild-type 2C scTCR on the surface of the yeast could not be detected with 1B2 (Fig. 1A) . However, both the HA tag and, to a lesser degree, the KJ16, F23.1, and F23.2 epitopes were detectable on the surface (see shoulders on peaks in Fig. 1 A; data not shown). Thus, properly associated wild-type V ␣ V ␤ protein was not displayed at the cell surface. The eukaryotic secretory pathway retains and degrades misfolded proteins, as shown for the assembly of the TCR-CD3 complex (21) . In yeast, secretion efficiency has been found to correlate with thermodynamic stability of a series of mutants of bovine pancreatic trypsin inhibitor (22) . As surface-displayed proteins are transported through the secretory pathway, we reasoned that TCR mutants with enhanced stabilities might enable functional cell surface expression.
Selection for Increased 1B2 ؉ Surface Levels from a Randomly Mutagenized TCR Library. To determine whether surface expression could be achieved by single-residue changes in the V ␣ or V ␤ domains, a randomly mutagenized library of 7 ϫ 10 6 cells was screened by flow cytometric sorting with the 1B2 antibody. The Aga-2p-TCR expression plasmid was randomly mutagenized by growth in the XL1-Red mutator strain of E. coli. Yeast were selected through three rounds of flow cytometric sorting after labeling with biotinylated 1B2 followed by SA-PE. Selected cells were plated, and expanded individual colonies were analyzed by flow cytometry with the panel of anti-TCR antibodies ( Figs. 1 and 2 ; data not shown). Individual colonies had various levels of 1B2 ϩ immunofluorescence (Fig. 2) . Among the different colonies, the fluorescence levels detected with 1B2 were directly proportional to the levels detected with the other anti-TCR antibodies (Fig. 1B  for mutant 15 ; data not shown for other single mutants).
Sequence Analysis of TCR Mutants. Sequencing of the scTCR genes that were rescued from 17 different colonies indicated that, in every case, there were single-site mutations in either the V ␣ or V ␤ region (data not shown). Among the 17 isolates, five unique mutations were observed: V ␣ L43P (mTCR7, 9 isolates), V ␣ L104P (mTCR16, 1 isolate), V ␤ A13V (mTCR2, 4 isolates), V ␤ G17E (mTCR15, 2 isolates), and V ␤ T105A (mTCR3, 1 isolate).
Cell-Surface Levels of Double and Triple TCR Mutants. To determine whether the effects of the mutations on the levels of surface scTCR were additive, three of the mutations (mTCR7, mTCR15, and mTCR16: V ␣ L43P, V ␤ G17E, and V ␣ L104P) were combined into double or triple mutants. Compared with the single mutants, all combinations had increases in 1B2 ϩ surface levels, and the triple mutant had the highest mean fluorescence level in the test (Figs. 1 C and D,  and 2 ). We conclude that the mechanism or mechanisms involved in the increased surface expression of these mutants seem to operate independently and that the mutations can be combined to engineer TCR display libraries with enhanced surface expression levels. In addition, the observation that the increased surface levels could be transferred by site-directed mutagenesis to produce double and triple mutants suggests that the effects are caused by the single-site mutations and not by mutations that reside outside of the coding region (e.g., in the promoter region). Finally, titrations of the mutants with the 1B2 antibody indicated that there was no overall increase (1999) in the affinity of the 1B2 antibody that could account for higher levels of 1B2 binding (data not shown). The total number of TCRs per yeast cell was estimated by using 125 I-labeled 1B2 Fab fragments: Ϸ10,000 for the single mutants (mTCR7, mTCR15, and mTCR16), Ϸ30,000 for the double mutant (mTCR7͞15), and Ϸ50,000 for the triple mutant (mTCR7͞15͞16). Although the number of TCRs per yeast cell is lower than the number of TCRs per 2C T cell (Ϸ100,000), the number of TCRs per unit area is considerably higher for yeast that express the double and triple TCR mutants than for 2C T cells (i.e., the diameter of 2C T cells is 2-3 times larger; thus, they have 4-to 9-fold more surface area than the yeast cells). (Fig. 3) . However, the TCR with the V ␣ L104P mutation (mTCR16 and the mTCR7͞15͞16 triple mutant), which is in CDR3, was not capable of binding QL9͞L d , at least within the detection limits of this assay. This result may not be surprising; the phenylalanine at position 100 within this CDR3 loop contributes binding energy to the QL9͞L d interaction (1), and a nonconservative CDR3 substitution such as proline could affect the conformation of the entire loop. Calculation of the approximate K D from these experiments (15 M) indicated that the affinity was 5-fold lower than that determined by using surface plasmon resonance with E. coli-derived 2C TCR (23) . This difference could be caused either by the difference in forms of the TCR analyzed (chip-immobilized sc-thioredoxin-V ␣ V ␤ vs. yeast-immobilized Aga-2-V ␣ V ␤ ) or by minor effects of the mutations themselves.
Location of Mutations in the TCR Structure. To explore the possible molecular basis for the effects of these mutations on yeast surface display, their positions in the 2C TCR structure (6, 24) were examined (Fig. 4) ; three of the mutations, V ␣ L43P, V ␣ L104P, and V ␤ T105A, reside at the interface of the V ␣ and V ␤ domains. The two other mutations, V ␤ A13V and V ␤ G17E, are located in the FR1 where in the full TCR a protruding knob in the C ␤ region is in proximity to the V ␤ region. The V ␣ L104P and V ␤ T105A interface mutations are located in the two CDR3 loops, within 5 Å of each other. The observation that the V ␣ L104P mutation also affects peptide͞ MHC binding has recent precedence, as a proline substitution within the CDR3 of a different TCR also affected peptide͞ MHC binding (presumably caused by changing the conformation of the CDR loop; ref. 25) . Interestingly, a recent alaninescanning mutagenesis study of the 2C TCR showed that V ␣ L104A reduced binding to QL9͞L d , whereas the V ␤ T105A mutation yielded a slight increase in affinity for the 1B2 antibody but had no effect on QL9͞L d (1) . Despite these effects on 1B2 or peptide͞MHC binding, the selection of mutations only in the CDR3, which are uniquely positioned among the six CDR at the V ␣ ͞V ␤ interface, suggests that they act by influencing the stability of the V ␣ ͞V ␤ interaction.
DISCUSSION
Selection of the displayed TCR mutants from a yeast library raises the question of how these specific mutations act in allowing surface expression. A clue to the mechanism comes from a comparative analysis of TCR and antibody V region sequences. The three framework mutations identified here, V ␤ A13V, V ␤ G17E, and V ␣ L43P, are found naturally in many V H and V L sequences (Table 1) . Valine is the most frequent residue in V ␣ , V H , and V sequences at the FR1 site corresponding to the V ␤ A13V mutant. Glutamic acid is the most frequent residue in V and the second most common residue in V ␣ and V at the FR1 site corresponding to the V ␤ G17E mutant. And perhaps most compellingly, proline is the most frequent residue in V ␣ , V , and V sequences at the FR2 site corresponding to the V ␣ L43P mutant. A leucine-proline V H ͞V L interaction across the Fv interface is highly conserved in antibodies (Ͼ90%; ref. 26) , and the V ␣ L43P mutation at position 43 introduces such a leucine-proline pair into the 2C scTCR interface. Thus, the added stability of this leucineproline interaction seems to facilitate secretion and display, perhaps through improvement in V ␣ ͞V ␤ (or V H ͞V L ) association. The presence of stability-increasing mutations at the interface has implications for preferential pairing between V ␣ and V ␤ regions, suggesting that pairing is nonrandom.
It is possible that antibody V regions evolved residues at these positions to facilitate high-level secretion in soluble form, and expression requirements for TCR V ␣ ͞V ␤ as part of a membrane complex may differ. The identification of FR1 mutations V ␤ A13V and V ␤ G17E raises the question of how this region of the TCR might differ from antibodies. One difference between TCRs and antibodies in this region is the presence of a negatively charged knob (Fig. 4) formed by residues Glu-221, Glu-222, and Asp-223 within the C ␤ (4). These residues are positioned 7-10 Å from the V ␤ FR1 region that contains the V ␤ A13V and V ␤ G17E mutations. Interestingly, V ␤ sequences from the Kabat database have a strong bias toward positive charges in this region of FR1, with a mean net charge of ϩ1.6 for residues 8-17 (56% of V ␤ sequences possess a net charge of 2 or greater). By contrast, V ␣ , V H , V , or V sequences have a mean net charge of ϩ0.4 or lower in this FR1 region and fewer than 2% possess net charges of 2 or higher. Thus, we predict that electrostatic interactions between V ␤ FR1 and the negatively charged C ␤ knob contribute to stabilization of the full TCR. The absence of the V ␤ ͞C ␤ knob interaction in the scTCR design might destabilize the fold, such that introduction of a more hydrophobic buried residue (V ␤ A13V) or a negative residue (V ␤ G17E) could stabilize the protein.
Consistent with the possibility that the C ␤ knob stabilizes the V ␤ region, studies have shown that TCR constructions that contain the C ␤ region are more stable than V ␣ V ␤ alone (27, 28) . During review of this manuscript, a study showed that phage display of a TCR was possible only when the C ␤ region was included (29) . We have shown that solubly expressed forms of mTCR7, mTCR15, and mTCR16 have enhanced thermal Immunology: Kieke et al. Proc. Natl. Acad. Sci. USA 96 (1999) stability compared with wild-type scTCR (data not shown), suggesting that it may be possible to stabilize V ␣ V ␤ pairs without including the entire C ␤ domain and without affecting peptide͞MHC reactivity. Finally, it is possible that the V ␤ ͞C ␤ knob interaction also may influence the signaling of a T cell through the TCR complex. This possibility is supported by a recent finding (30) that one of the two CD3 subunits is associated with the TCR near the C ␤ knob (called C ␤ FG loop in the study). One prediction from this idea is that introduction of the V ␤ FR1 mutations described here into a full TCR expressed on a T cell may affect signaling functions. Expression of the HA tag on the surface of yeast cells that contain the wild-type TCR construct (Fig. 1 A) indicated that this region of the Aga-2 fusion protein was transported correctly through the secretory pathway. Both the F23.1 and F23.2 antibodies (anti-V ␤ 8) also showed some reactivity with the wild-type TCR construct. In contrast, antibody 1B2, which requires both V ␣ and V ␤ domains for reactivity, did not bind to yeast that contain the wild-type TCR plasmid. Thus, the Aga-2-HA-V ␤ -linker-V ␣ construction showed highest reactivity with antibodies that recognize the most amino-terminal regions (Aga-2 Ͼ V ␤ Ͼ V ␣ ). Recently, we have shown that the HA-positive protein on the surface of the wild-type TCR yeast has been cleaved, accounting for its lower level of reactivity with the other antibodies (E.V.S., M.C.K., E. A. Parke, D.M.K., and K.D.W., unpublished work). Thus, less stable V ␣ ͞V ␤ domains seem to be more susceptible to intracellular proteases.
The results described here suggest that the yeast surfacedisplay system could be useful for genetic engineering of T cell Comparison of amino acid frequencies in TCR (V␣ and V␤) and antibody (VH, V, V) variable regions. Residues found at the three framework positions indicated by mutants from the TCR͞yeast display system are found naturally in antibodies. Values determined by searches of ALL IG and ALL TCR V region sequences (Kabat database, immuno.bme.nwu.edu, 11͞97 data sets).
FIG. 4. X-ray crystallographic structure of 2C TCR with mutated residues highlighted. The 2C TCR structure (6) is shown with residues isolated as mutants in the yeast display system highlighted. The FR2 interface mutation is colored green. The CDR3 interface mutations are colored orange. First-framework-region (FR1) mutations proximal to the C␤ ''knob'' (in the full TCR) are colored purple. There are three negatively charged C␤ knob residues (Glu-221, Glu-222, and Asp-223) indicated in red.
Immunology: Kieke et al. Proc. Natl. Acad. Sci. USA 96 (1999) 5655 receptors by combinatorial library screening. As there are a number of V ␣ and V ␤ regions that share the particular residues identified here with the 2C TCR, the single-site changes are likely to show similar effects for other TCRs. The specific mutations thus may allow the expression of other TCR V ␣ ͞V ␤ regions that have been problematic. As has been shown by using different scFv antibodies in the yeast display system, it may now be possible to isolate TCR variants with higher antigen-binding affinities. By analogy to the variety of therapeutic antibody applications resulting from phage-display technology, one might expect numerous applications that derive from the generation of stable, high-affinity T cell receptor fragments. Finally, there are many proteins that have inherent difficulties in expression as fusion proteins on the surface of phage. As shown here, these difficulties might be overcome by combining a eukaryotic expression system with a strategy of random mutagenesis and selection to isolate mutants that are expressed at high levels on the yeast cell surface.
